Export 4 results:
Author Title [ Type(Desc)] Year
Filters: Author is Deye, Gregory A  [Clear All Filters]
Journal Article
M. B. Laurens, Berry, A. A., Travassos, M. A., Strauss, K., Adams, M., Shrestha, B., Li, T., Eappen, A., Manoj, A., Abebe, Y., Murshedkar, T., Gunasekera, A., Richie, T. L., Lyke, K. E., Plowe, C. V., Kennedy, J. K., Potter, G. E., Deye, G. A., Sim, B. K. L., and Hoffman, S. L., Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults., J Infect Dis, vol. 220, no. 12, pp. 1962-1966, 2019.
M. H. Collins, Potter, G. E., Hitchings, M. D. T., Butler, E., Wiles, M., Kennedy, J. K., Pinto, S. B., Teixeira, A. B. M., Casanovas-Massana, A., Rouphael, N. G., Deye, G. A., Simmons, C. P., Moreira, L. A., Nogueira, M. L., Cummings, D. A. T., Ko, A. I., Teixeira, M. M., and Edupuganti, S., EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil., Trials, vol. 23, no. 1, p. 185, 2022.
D. A. J. Friedman-Klabanoff, Berry, A. A., Travassos, M. A., Cox, C., Zhou, Y., Mo, A. X., Nomicos, E. Y. H., Deye, G. A., Pasetti, M. F., and Laurens, M. B., Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing., Vaccine, vol. S0264-410X(20)31590, 2021.
S. C. Murphy, Deye, G. A., B Sim, K. Lee, Galbiati, S., Kennedy, J. K., Cohen, K. W., Chakravarty, S., Kc, N., Abebe, Y., James, E. R., Kublin, J. G., Hoffman, S. L., Richie, T. L., and Jackson, L. A., PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection., PLoS Pathog, vol. 17, no. 5, p. e1009594, 2021.